Core Viewpoint - Mosaic Co (NYSE:MOS) has seen an 18% increase in stock price since the beginning of the year, but may face a short-term pullback due to a historically bearish trendline [1] Group 1: Stock Performance and Trends - The stock is currently within 0.75 of the 126-day moving average's 20-day average true range (ATR), having remained below this level 80% of the time over the past two weeks and 80% of the last 42 trading sessions [2] - Historical data shows that similar signals have occurred 17 times in the past decade, with the stock declining one month later 76% of the time, averaging a 5.7% loss [2] - A potential decline from the current price of $28.47 could bring the stock down to approximately $26.84 [2] Group 2: Technical Indicators - The 14-day Relative Strength Index (RSI) for Mosaic stock is at 75.1, indicating it is in "overbought" territory [4] - Options for the stock appear affordable, with a Schaeffer's Volatility Index (SVI) of 39% ranking in the 23rd percentile of its annual range [4] - The Schaeffer's Volatility Scorecard (SVS) for MOS is high at 91 out of 100, suggesting that the stock has exceeded option traders' volatility expectations over the past year [4]

Core Viewpoint - The Argentine Ministry of Economy, in collaboration with SENASA and INTA, has launched a new manual aimed at simplifying the registration process for agricultural protection products, particularly for niche crops and minor uses in major crops [1] Group 1: Regulatory Changes - The new regulations are established through Resolution No. 458/2025 and amended by Resolution No. 843/2025, set to take effect on January 5, 2026 [1] - These resolutions modernize the national registration framework for agricultural protection products, with the goal of accelerating the approval process [1] Group 2: Impact on Agricultural Producers - Agricultural producers, especially those growing niche crops such as legumes, fruits, vegetables, and spices, will benefit from shorter timelines to obtain necessary agricultural protection products [1] - The new regulations aim to reduce the costs associated with the registration process for these products [1] Group 3: Collaborative Efforts - SENASA will work alongside INTA, universities, research institutions, experts in agricultural protection products, provincial governments, and producer organizations to advance product development and authorization [1] - A permanent working group will be established to focus on the research and development needs for agricultural protection tools and alternatives, particularly expanding the registration coverage for products related to niche crops [1]

Core Insights - Riverwater Partners' "Micro Opportunities Strategy" faced challenges in Q4 and FY2025, underperforming against benchmarks due to underweight exposure in speculative market areas [1] - The strategy's focus on high-quality stocks lagged behind the performance of low-quality stocks, which outperformed the market [1] - Looking ahead to 2026, the strategy aims to concentrate on micro-cap companies with broader sales and growth trajectories, anticipating that the rallies in low-quality stocks will be short-lived [1] Company-Specific Insights - American Vanguard Corporation (NYSE:AVD) was highlighted as a performance detractor in Q4 2025, with a one-month return of 10.82% but a 52-week loss of 15.35% [2] - Despite operational improvements under new management, American Vanguard's stock price declined, illustrating inefficiencies in micro-cap equities [3] - Key operational metrics for American Vanguard include a 20% year-over-year reduction in inventory levels and an increase in gross margins from 15% to 29%, with adjusted EBITDA rising from $2 million to $8 million [3]

Core Viewpoint - Deere & Company is positioned as a leader in the agricultural sector, leveraging AI and automation to enhance farming efficiency, while FMC faces significant challenges due to declining demand for agricultural chemicals [1][10][11]. Group 1: Deere & Company Overview - Deere & Company, commonly known as John Deere, has been a significant player in agriculture since its founding in 1837, providing a wide range of farming equipment [3]. - The company is innovating with digital tools, AI, and autonomous driving technology to improve farming practices [4][8]. - In 2023, Deere's smart sprayers demonstrated a 50% reduction in water and chemical use, an 87% reduction in airborne drift, and a 93% reduction in chemical runoff during testing on 1 million acres [6][7]. Group 2: Financial Performance of Deere - Despite a challenging year in 2025, where net sales and revenue decreased by 12% and net income fell by 29%, Deere maintains a net income margin of 11% and has increased its dividend by 113% since 2020 [8][9]. - For Q4 2025, Deere reported an 11% increase in net sales and revenue, indicating a recovery trend as it continues to invest in technology [9]. Group 3: FMC Overview - FMC specializes in developing and producing pesticides and other agricultural chemicals, but is currently facing severe financial difficulties [11]. - In Q3 2025, FMC reported a 49% decline in revenue, dropping from over $1 billion to $542 million, and a net income loss of $569 million compared to a profit of $66 million in Q3 2024 [13][14]. Group 4: Financial Performance of FMC - FMC's earnings per share plummeted from $0.52 in Q3 2024 to a loss of $4.52 per share in Q3 2025, reflecting the company's struggles [13]. - The company's free cash flow is projected to decline from $614 million in 2024 to a loss of $100 million in 2025, coinciding with the rise of technologies that reduce pesticide use [14].

Core Viewpoint - FMC Corporation's shares experienced a significant decline of 71.5% in 2025, prompting the CEO to declare a "reset year" for the company, indicating ongoing challenges into 2026 [2][3]. Financial Performance - FMC's revenue, profits, and cash flow decreased throughout 2025 due to high interest rates affecting customer payments in South America and increased pricing pressure from generic competition as some higher-margin chemicals went off-patent [3]. - The company missed revenue expectations in both February and October earnings reports, with a full-year revenue guidance of $4.15 billion to $4.35 billion, falling short of the $4.40 billion analyst consensus [5][8]. - In October, FMC reported a 49% decline in headline revenue due to the sale of its India business, with an adjusted revenue decrease of 10% for the quarter [7]. Strategic Actions - Management announced aggressive pricing actions to counter competition from generic brands, alongside cost-cutting measures and a shift to direct sales to large growers in South America [5]. - FMC's dividend was cut by 86%, reflecting the company's financial struggles and the need for retrenchment [4][8]. Market Position - Following the stock decline, FMC was removed from the S&P 500 index, indicating a shift in market perception and size relative to other companies [6]. - Despite the stock appearing cheap, FMC carries a significant debt load, and a turnaround is not anticipated until 2028 [8].

Core Insights - BASF SE's Agricultural Solutions unit and ADAMA Ltd. have formed a strategic partnership to co-develop and commercialize ADAMA's proprietary fungicide active ingredient, Gilboa, aimed at enhancing disease management solutions for European farmers [1][2] Group 1: Partnership Details - The collaboration will leverage BASF's development expertise and market access in Europe, while both companies will independently manage their product concepts, pricing, and sales strategies [2] - Gilboa is classified under the Fungicide Resistance Action Committee (FRAC) Group 32, targeting nucleic acid metabolism, and offers a new solution to regulatory challenges and the phase-out of existing active ingredients in Europe [3][7] Group 2: Product Launch Timeline - Gilboa-based formulations for wheat are expected to be launched in Great Britain by 2027, with broader European launches planned for 2029, subject to regulatory approval [4][7] Group 3: Market Performance - BASF's shares have increased by 20.4% over the past year, contrasting with a 13.9% decline in the industry [4]

Core Viewpoint - FMC has experienced significant declines in share price and total returns over the past year, leading to concerns about its financial health and future performance [3][5][6]. Investment Performance - FMC's share price decreased by 75.8% over the year leading up to December 11, while the S&P 500 index gained 13.4% during the same period [3]. - The total return for FMC, which includes price changes and dividend payments, was negative 74.4%, compared to a positive return of 14.9% for the S&P 500 [3]. Current Financial Metrics - FMC's current market capitalization is $1.7 billion, with a current share price of $13.91 [4][5]. - The company's gross margin stands at 37.10%, and the dividend yield is reported at 16.68% [5]. Dividend Changes - FMC's board of directors has reduced the quarterly dividend by over 86% to $0.08 per share, indicating financial distress [5][6]. Revenue and Earnings Outlook - The company reported an 11% drop in adjusted third-quarter revenue and has lowered its full-year revenue outlook, now anticipating a 7% decline [6]. - The price-to-sales (P/S) ratio for FMC has fallen from 1.6 to 0.5 over the past year, suggesting a potential value trap due to ongoing top-line challenges and cash flow issues [7].

Core Thesis - FMC Corporation is viewed positively due to its potential turnaround following a significant stock decline and easing destocking headwinds, supported by a strong innovation pipeline and favorable market conditions [2][4]. Company Overview - FMC Corporation is a global agricultural chemical company specializing in herbicides, fungicides, and insecticides, with a strong research pipeline and intellectual property [2]. - The company's stock was trading at $13.84 as of December 1st, with trailing and forward P/E ratios of 30.22 and 5.92 respectively [1]. Financial Performance - FMC has experienced a 75% stock decline from 2022 highs, attributed to a destocking cycle and weaker pricing, but is now trading at historically low valuation levels [2]. - The company maintains a strong balance sheet with manageable debt maturities starting in 2029 and ample liquidity, aiming for a 7%+ dividend yield [4]. Growth Drivers - FMC's innovation-led model, featuring patented molecules and new products, positions the company for renewed growth, particularly in expanding markets like Brazil and Latin America [3]. - The biologicals segment is growing over 20% annually, supported by favorable industry trends related to global food demand [3]. Strategic Initiatives - FMC is divesting its low-margin India commercial business to focus on higher-return opportunities and is establishing a direct-to-grower sales model in Brazil [3]. - Management's targets for 2027 and normalized free cash flow assumptions suggest a fair value estimate of $75–$80 per share, indicating nearly 2.5x upside from current levels [4].

Core Insights - The company faced significant challenges over the past year, prompting a reassessment of its strategies and operations [1] - The CEO reflected on the initial expectations versus the actual outcomes, indicating a need for strategic adjustments [1] Financial Strategy - The company aimed for a soft landing by balancing EBITDA protection while gradually paying down debt and maintaining dividends [2] - Key focus areas included managing inventory levels in the channel, addressing the Rynaxypyr strategy, and reshaping leadership in India [2]

Core Insights - Bayer Crop Science Canada has launched EverGol® Rise, which sets a new standard in pulse disease control [1] - The product combines four different active ingredients to enhance disease control against tough pathogens like ascochyta [1] - The focus on user ease of use is emphasized, indicating a commitment to improving the farming experience [1] Product Details - EverGol Rise is designed to provide enhanced disease control for Canadian farmers [1] - The product aims to transform farming practices by maximizing every minute spent on the farm [1]